Efficacy of a novel interferon alpha B/D, given in high dose. Monitored by quantitative HBeAg, HBsAg and HBV-DNA in patients with chronic hepatitis B.

被引：0
|
作者：
Rasch, MC
vanHattum, J
vanDijck, CMM
Haagsman, EB
Michielsen, P
Schellekens, H
机构：
[1] UNIV UTRECHT HOSP,DEPT GASTROENTEROL,UTRECHT,NETHERLANDS
[2] UNIV GRONINGEN HOSP,GRONINGEN,NETHERLANDS
[3] SSDZ,DELFT,NETHERLANDS
[4] UNIV HOSP,ANTWERP,BELGIUM
来源：
HEPATOLOGY | 1996年 / 24卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：612 / 612
页数：1
相关论文
共 50 条
  • [21] Differential HBV RNA and quantitative HBsAg kinetics between HBeAg(+) and HBeAg(-) patients with chronic hepatitis B on nucleos(t)ide analogues (NA)
    Shah, Pir Ahmad
    Ishtiaq, Rizwan
    Kaur, Satinder Pal
    Gersch, Jeffrey
    Choudhry, Saad
    Kuhns, Mary
    Cloherty, Gavin
    Lau, Daryl
    JOURNAL OF HEPATOLOGY, 2020, 73 : S836 - S836
  • [22] Low serum HBsAg and HBV DNA predict response of peg-interferon addition to entecavir in HBeAg positive chronic hepatitis B
    Liem, S.
    Hansen, B.
    Xie, Q.
    Liang, C.
    Brouwer, W. P.
    Chi, H.
    Guo, S.
    Qi, X.
    Zhang, N. -P.
    Fehmi, T.
    Campenhout, M. V.
    Janssen, H.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S518 - S519
  • [23] Correlation of hepatitis B virus genomic variants with HBsAg Titers and HBV-DNA levels in a large European study cohort of patients with chronic hepatitis B
    Peiffer, K. -H.
    Sommer, L.
    Susser, S.
    Dietz, J.
    Vermehren, J.
    Knop, V.
    Zeuzem, S.
    Hildt, E.
    Sarrazin, C.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S248 - S248
  • [24] USE OF HBV-DNA AS A GUIDE TO ALPHA-INTERFERON (AIFN) THERAPY FOR CHRONIC ACTIVE HEPATITIS-B (CAHB)
    COOMES, J
    TAMBURRO, CH
    HEPATOLOGY, 1989, 10 (04) : 690 - 690
  • [25] SERUM HBSAG LEVELS REFLECT INTRACELLULAR HBSAG, BUT NOT CCCDNA OR TOTAL LIVER HBV DNA IN PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITIS B
    Manesis, Emanuel K.
    Papatheodoridis, George V.
    Tiniakos, Dina
    Hadziyannis, Emilia
    Agelopoulou, Olga P.
    Syminelaki, Thalia
    Papaioannou, Christos
    Nastos, Theodoros
    Karayannis, Peter
    HEPATOLOGY, 2009, 50 (04) : 969A - 970A
  • [26] Intrahepatic HBV DNA as a predictor of antivirus treatment efficacy in HBeAg-positive chronic hepatitis B patients
    Hadad Ivan
    World Journal of Gastroenterology, 2007, (20) : 2878 - 2882
  • [27] Intrahepatic HBV DNA as a predictor of antivirus treatment efficacy in HBeAg-positive chronic hepatitis B patients
    Lu, Hai-Ying
    Zhuang, Li-Wei
    Yu, Yan-Yan
    Ivan, Hadad
    Si, Chong-Wen
    Zeng, Zheng
    Li, Jun
    Hou, Dong-Ming
    Chen, Xin-Yue
    Han, Zhong-Hou
    Chen, Yong
    WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (20) : 2878 - 2882
  • [28] SERUM HBSAG AND HBV DNA AMONG HBEAG POSITIVE AND NEGATIVE CHRONIC HEPATITIS B PATIENTS DURING ADEFOVIR DIPIVOXIL THERAPY
    Ayana, Desalegn A.
    Jiang Yanfang
    Cai Yanjun
    Niu Junqi
    HEPATOLOGY, 2009, 50 (04) : 541A - 542A
  • [29] HBV DNA change between HBeAg positive and negative patients with chronic hepatitis B
    Liu, J.
    Zhang, J.
    Lin, C. -S.
    Xu, Z.
    Gao, Z. -L.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2011, 15 : S29 - S29
  • [30] HBV DNA suppression and HBsAg clearance in HBeAg negative chronic hepatitis B patients on lamivudine therapy for over 5 years
    Fasano, Massimo
    Lampertico, Pietro
    Marzano, Alfredo
    Di Marco, Vito
    Niro, Grazia Anna
    Brancaccio, Giuseppina
    Marengo, Andrea
    Scotto, Gaetano
    Brunetto, Maurizia Rossana
    Gaeta, Giovanni Battista
    Rizzetto, Mario
    Angarano, Gioacchino
    Santantonio, Teresa
    JOURNAL OF HEPATOLOGY, 2012, 56 (06) : 1254 - 1258
12345